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The replicative lifespan of human keratinocytes in culture is restricted by a telomere-unrelated induction of
p16INK4A (p16) and p14ARF. We have found that, in vivo, p16 is expressed by epidermal and oral keratinocytes at the
migrating fronts of healing wounds and at the stromal interface of severely dysplastic and early invasive lesions
and that such cells also invariably display increased expression of Laminin 5 (Lam5). In culture, p16 and Lam5 are
coexpressed in keratinocytes at senescence, at the edges of wounds made in conﬂuent cultures, and when cells
are plated on dishes coated with the c2 precursor form of Lam5 (Lam5c2pre). Lam5/p16 coexpression in all three
in vitro settings is associated with directional hypermotility and growth arrest. Hypermotility and growth arrest are
uncoupled in p16- and p14ARF/p53-deﬁcient keratinocytes and squamous cell carcinoma (SCC) cells; such cells
become hypermotile is response to Lam5c2pre but do not growth arrest. Thus, the Lam5/p16 response is activated
in normal wound healing, causing growth arrest of migratory keratinocytes that lead wound reepithelialization. This
response also becomes activated at a critical stage of neoplastic progression, acting as a tumor suppressor
mechanism. Rare premalignant cells that lose p16 remain motile and proliferative, thereby resulting in invasive
growth as SCC.
Key words: epidermis/human cells/senescence/tumor suppressor
J Investig Dermatol Symp Proc 10:72 –85, 2005
Squamous cell carcinoma (SCC) is a malignancy of the oral
mucosal epithelium, the epidermis, and other stratified
squamous epithelia. SCC arise within areas of abnormal,
preinvasive cell growth (dysplasia), which may take many
years to progress to invasive cancer (Bouquot et al, 1998;
Mashberg and Feldman, 1998; Lee et al, 2000b). A con-
sistent feature of invasive SCC and detectable in many
premalignant dysplasias is loss, by mutation, deletion, or
promoter hypermethylation, of the ability to express func-
tional p16INK4A (p16) (Kamb et al, 1994; Yeudall et al, 1994;
Merlo et al, 1995; Shapiro et al, 1995; Califano et al, 1996;
Reed et al, 1996; Olshan et al, 1997; Papadimitrakopoulou
et al, 1997; Soufir et al, 2000; Poi et al, 2001; reviewed by
Rocco and Sidransky, 2001). p16 is a specific inhibitor of
the cyclin D1-dependent kinases cdk4 and cdk6 (Serrano
et al, 1993; Parry et al, 1995) (see Fig 1). Normally, cells do
not express p16 and whether cells cycle or not is controlled
by cyclin D1, the expression of which is regulated by mi-
togen availability and cell–substratum anchorage. Cyclin D1
forms complexes with and activates cdk4 and cdk6, which
phosphorylate and inactivate the Rb protein, permitting
E2F-dependent transcription of genes whose products are
necessary to permit the G1/S transition and initiate chro-
mosome replication (reviewed by Sherr, 1996).
Western blot analysis of normal primary human keratin-
ocytes in culture has identified an increase in p16 levels with
serial passage, as the cells approach the end of their rep-
licative lifespan (Loughran et al, 1996; Kiyono et al, 1998;
Munro et al, 1999; Dickson et al, 2000; Lee et al, 2000a).
Immunocytochemical analysis of such cultures has revealed
that p16 expression occurs heterogeneously and abruptly,
followed by growth arrest, and that the probability that a
keratinocyte will express p16 increases steadily with each
passage until all cells are p16-positive and senescent (Di-
ckson et al, 2000; Rheinwald et al, 2002). Our studies have
provided strong evidence that, if p16 expression fails to ar-
rest growth, induction of p14ARF expression follows soon
thereafter to effect a p53-dependent, p21cip1-enforced ar-
rest in either G1 or G2, as described in Rheinwald et al
(2002) and summarized in the model shown in Fig 2. Ker-
atinocytes engineered to express the catalytic subunit of
telomerase, TERT, extend and stabilize their telomeres; yet,
still they undergo p16-enforced senescence (Kiyono et al,
1998; Dickson et al, 2000). This fate can be mofified by
mutational, epigenetic, or regulatory loss/reduction of p16
expression in TERT-transfected cells, yielding immortalized
lines (Kiyono et al, 1998; Dickson et al, 2000; Farwell et al,
2000; Rheinwald et al, 2002). p16-enforced keratinocyte
Abbreviations: BUdR, bromodeoxyuridine; CM, conditioned medi-
um; g2pre, g2 precursor form of Laminin 5; HPV, human pap-
illomarinus; KMA, keratinocyte motility/arrest; K-sfm, keratinocyte
serum-free medium; Lam5, Laminin 5; p16, p16INK4A; PD, popu-
lation doublings
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senescence is distinct from the telomere-sensitive, p53/
p21cip1-dependent replicative senescence mechanism that
enforces the replicative lifespan limit of human skin fibro-
blasts and several other cell types (Bond et al, 1994; Brown
et al, 1997; Stein et al, 1999; Rheinwald et al, 2002).
Humans and mice that inherit a heterozygous or ho-
mozygous loss of function mutation in the p16 gene (Gruis
et al, 1995; Sharpless et al, 2001, 2004) or that express a
p16-insensitive mutant form of cdk4 (Rane et al, 2002) are
predisposed to a variety of spontaneous and carcinogen-
induced cancers, but they undergo normal development
and form structurally and functionally normal stratified
squamous epithelia. These results confirm the tumor sup-
pressor function of p16 and are also consistent with the
finding that p16 protein is not expressed as a feature of
normal stratified squamous epithelial renewal or differenti-
ation (Nielsen et al, 1999; Keating et al, 2001; Klaes et al,
2001). The stage of neoplastic progression toward SCC at
which the p16 protein becomes expressed and functions as
a tumor suppressor was revealed by our recent study,
summarized below, in which we characterized p16 expres-
sion immunohistochemically in a set of normal, benign
hyperplastic, pre-invasive, and invasive epithelial tissue
specimens from the skin and oral mucosa (Natarajan et al,
2003). p16 proved to be expressed heterogeneously in cells
of some premalignant lesions and consistently in areas of
microinvasion and at superficial margins of invasive SCC.
As described below, we found (Natarajan et al, 2003) that
the p16-expressing cells in such lesions also express great-
ly increased levels of Laminin 5 (Lam5), previously identified
as a marker of invasion in many types of epithelial cancers
(Pyke et al, 1995; Kainulainen et al, 1997; Lohi, 2001; Le-
nander et al, 2003). Lam5 is a three-chain heterotrimeric
protein and an important component of the basement
membrane of stratified squamous epithelia (Carter et al,
1991; Rousselle et al, 1991). The trimer of a3, b3, and g2
chains is synthesized by keratinocytes as an Mr  460 kDa
precursor form and processed by cleavage of the a3 and g2
chains at specific sites (Fig 3) by BMP1/Tld and other pro-
teases (Marinkovich et al, 1992; Goldfinger et al, 1998;
Amano et al, 2000; Veitch et al, 2003) to an Mr  400 kDa
mature form. In their normal, undisturbed state in vivo, basal
keratinocytes maintain an intact, continuous layer of mature
Lam5 beneath them, to which they adhere via a6b4 integrin
to form stable, anchoring hemidesmosome (HD) structures.
In HD, a6b4 integrin forms clusters and associates closely
with the transmembrane BP180 protein; the cytoplasmic
domains of these proteins form stable connections with the
cytokeratin filament network, mediated by BPAG1 and
plectin (Baker et al, 1996; reviewed by Jones et al, 1998;
Van der Flier and Sonnenberg, 2001). Keratinocytes at the
migrating front of wounds express high levels of Lam5 and
display an increased expression and unpolarized distribu-
tion of a6b4, a3b1, and a2b1 integrins (Larjava et al, 1993;
Figure 1
Mechanism of action of p16INK4A as a cell cycle inhibitor causing
G1 arrest.
Figure 2
Model of the dual, p16INK4A and p14ARF-enforced, telomere status-
independent mechanism of keratinocyte senescence.
Figure3
Laminin 5 (Lam5) structure. Lam5 is secreted as a three-chain hete-
rotrimer, which is normally processed proteolytically soon after secre-
tion in the g2 chain and a3 chain at the sites indicated by large blue
arrows. The g2 chain is subject to further processing during some de-
velopmental processes and in some carcinomas by cleavage at the site
indicted by the small black arrow.
LAMININ 5 AND p16INK4A IN KERATINOCYTE MOTILITY 7310 : 2 NOVEMBER 2005
Dabelsteen et al, 1998; Kainulainen et al, 1998; Goldfinger
et al, 1999; Nguyen et al, 2000a, b). Following the initial
observation by Kikkawa et al. (1994) that a form of Lam5
secreted by some carcinoma cell lines induces colony
scattering, Zhang and Kramer (1996) reported that ex-
ogenously applied Lam5 promoted a3b1 integrin-depend-
ent keratinocyte motility as measured by a Boyden
chamber/transwell migration assay. Subsequent studies
by Goldfinger et al. (1999); Nguyen et al. (2000a, b), and
Decline and Rouselle (2001) provided evidence that re-
duced ligation of mature Lam5 to a6b4 integrin and in-
creased ligation of precursor Lam5 to b1 integrins,
principally a3b1, results in keratinocyte motility at the lead-
ing edge of healing wounds.
Interestingly, Lam expression is increased in p16-posi-
tive, senescent normal keratinocytes in late passage cul-
tures, associated with a remarkable directional hypermotility
(Natarajan et al, 2003). As described below, we have found
that coordinate Lam5 and p16 expression occurs in normal
wound healing. We have identified an experimental system
for inducing this response acutely and synchronously in
culture and have used this system to characterize the fun-
damental elements of a keratinocyte motility/growth arrest
(‘‘KMA’’) mechanism, in which certain changes in cell–sub-
stratum adhesion induce directional hypermotility followed
by an increase in p16 expression and growth arrest (Natara-
jan et al., submitted).1
Results
p16-related keratinocyte senescence mechanism and
immortalization barrier Our initial investigations confirmed
and extended the findings of Kiyono et al (1998), that the
expression of TERT in keratinocytes via stable retroviral
transduction results in telomere maintenance but is insuf-
ficient by itself to produce an immortalized line. We found
(see Dickson et al, 2000) that rare, immortalized variants
frequently emerged from a TERT-transduced population
following either a short and subtle, or a prolonged and ob-
vious, ‘‘slow growth phase’’ (SGP), during which most of the
cells underwent p16-enforced senescence (as in the exam-
ple in Fig 4a of the emergence of N/TERT-1 from the primary
newborn foreskin keratinocyte line strain N). In some TERT-
transduced keratinocyte populations, rapidly dividing im-
mortalized (RDI) variants emerged. Some of these were as-
sociated either with complete loss, by deletion or other
mechanisms, of p16 expression. Other TERT-transduced,
immortalized keratinocyte lines we generated proved to
evade p16-related arrest by markedly reducing the fre-
quency with which p16-expressing, growth-arrested cells
are produced during serial passage, rather than by muta-
tional loss or promoter silencing of the p16 locus (Dickson
et al, 2000). All the TERT-immortalized lines that we gen-
erated retained a normal p53-dependent DNA damage ar-
rest response, but some had p14ARF deletions.
Interestingly, TERT-transduced keratinocytes cultured
from a p53 (þ /) individual (Li–Fraumeni hereditary pre-
disposition to cancer syndrome) proved to select for loss
of the wild-type p53 allele following attenuation of p16
Figure4
The p16INK4A-dependent barrier to human keratinocyte immortal-
ization in culture can be bypassed by spontaneous mutations or by
genetic engineering to evade p16INK4A and p14ARF/p53-dependent
arrest mechanisms. Panel a summarizes the results described in Di-
ckson et al. (2000). The inset photographs show examples of cultures
immunostained for p16 at various stages in the lifespan of primary ker-
atinocytes and TERT-transduced keratinocytes. Normal primary human
keratinocytes, such as strain N depicted in this panel, can be serially
passaged in suitable culture medium formulations for as many as 60
population doublings (PD) before senescence (asterisk), associated with
induction of p16 expression in all cells. Cells stably transduced to ex-
press TERT at the point in their lifespan indicated by the downward red
arrow maintain long telomeres but enter senescence at the same time as
untransduced control cells. TERT-expressing keratinocyte populations
exhibit a ‘‘slow growth phase (SGP)’’ of indefinite length (nine passages
over 2 mo in this experiment) in which only a small subpopulation re-
mains p16-non-expressing and proliferative, and may produce rare var-
iants in which a second event has occurred, associated with complete
loss (upper right photograph, N/TERT-1) or greatly reduced frequency
(lower right photograph, N/TERT-2G) of p16 expression occurs, permit-
ting the cells to divide rapidly and without limit as an immortalized line.
Panel b summarizes the results described in Rheinwald et al. (2002).
Strain N cells transduced to express either the p16-non-binding mutant
cdk4R24C (cdk4R) or a dominant-negative p53 (p53DD) senesce (asterisk)
after about the same number of population doublings as the untrans-
duced control cells, but doubly transduced (p53DDþcdk4R) cells
evade senescence and divide for an additional 25–35 PD before being
limited by very short telomere crisis. These cells become ‘‘directly’’ im-
mortalized after transduction to express TERT, without requiring the ac-
quisition of further complementary second events.
1Natarajan E, Omobono JD II, Guo Z, Hopkinson S, Lazar AJF,
Brenn T, Jones IC, Rhein Wald JG: A keratinocyte hypermotility
growth arrest response activated by Lamin5 and dependent upon
the TGFB receptor and p16INK4A (submitted).
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expression (Dickson et al, 2000). This result was consistent
with our subsequent study (Rheinwald et al, 2002), in which
we genetically engineered normal keratinocytes to bypass
senescence and continue dividing to short telomere crisis.
Those experiments showed that, in order to evade their se-
nescence arrest mechanism, keratinocytes require abroga-
tion of both p16 and p53 function, accomplished by
sequential retroviral transduction to express a p16 non-
binding mutant form of cdk4 (cdk4R24C (Wolfel et al, 1995))
and a dominant-negative p53 (p53DD; Shaulian et al, 1992)
(Fig 4b). Keratinocytes in which both p16 and p53 were
missing or rendered nonfunctional proved to be directly
immortalized following transduction to express TERT. Sup-
porting this result, we found that keratinocytes cultured
from a p16 (þ /) individual (familial melanoma hereditary
predisposition to cancer syndrome) underwent selection for
a spontaneously arising, extended lifespan variant that lost
the wild-type p16 allele, dependent upon experimental
p53DD expression to abrogate the other, p53-dependent
component of p16-related senescence (Rheinwald et al,
2002).
Two types of experiments showed that the p16-depend-
ent component of the dual, p16- and p14ARF-dependent
keratinocyte senescence mechanism is activated first and
enforces growth arrest. First, whether cultured in K-sfm or in
the fibroblast feeder system, senescence arrest proved to
correlate tightly with high levels of p16, identified by BUdR/
p16 double immunocytochemical staining (Rheinwald et al,
2002) (Fig 5a). Second, two-channel flow cytometry, meas-
uring DNA content by propidium iodide fluorescence and
cycling vs. non-dividing state by BUdR immunofluores-
cence following a 24 h labeling period, showed that kera-
tinocytes arrest with a G1 DNA content, as expected for
p16-enforced arrest (Gray and Rheinwald, unpublished) (Fig
5b). This result was very different from that of senescing
fibroblasts, which arrested in either G1 or G2 (in a ratio
similar to their G1/G2 distribution during exponential
growth) as a result of telomere erosion-triggered, p53-de-
pendent, p21cip1-enforced arrest (data not shown).
The p53-dependent component of keratinocyte senes-
cence proved to be activated by a signal other than telo-
mere shortening (Rheinwald et al, 2002). Keratinocytes
sequentially transduced to express cdk4R and TERT were
not immortalized, but an immortalized variant arose from
within this population that proved to have acquired a func-
tion-impairing mutation in p53. Furthermore, immunocyto-
chemical staining and western blot analysis showed that, in
keratinocytes engineered to resist p16 and to block p53
function, both p16 and ARF levels increased in cells just at
the time when they began dividing beyond their normal
replicative lifespan limit. These results support the sequen-
tial, two-stage model of the p16-enforced keratinocyte se-
nescence arrest mechanism and immortalization barrier
shown in Fig 2.
p16 expression during neoplastic progression to squa-
mous cell carcinoma We next sought to determine the
setting in which p16 becomes expressed in keratinocytes
in vivo to function as a tumor suppressor mechanism. We
examined sets of normal, benign hyperplastic, dysplastic,
carcinoma in situ, and invasive SCC lesions of human
oral mucosa and epidermis (Natarajan et al, 2003). Our
initial hypothesis, based on our observation of increased
frequency of p16 expression with serial passage of
normal primary keratinocytes, was that excessive cell divi-
sion in vivo, as would occur in chronic benign epithelial
hyperplasia or premalignant dysplasia, would trigger p16
expression. We found, however, that benign hyperplastic
lesions never contained p16-positive cells, but that p16 was
expressed by cells engaged in or about to begin neoplastic
Figure5
Keratinocytes cultured in optimized culture systems senesce in
G1, following their induction of p16INK4A expression. Panel a shows
mid-to-late lifespan cultures of strain N keratinocytes cultured in GIB-
CO ker-sfm medium (a, b) or in the 3T3 fibroblast feeder layer system
(c, d). Bromodeoxyuridine (BUdR) was added to the medium 24 h be-
fore cultures were fixed and enzymatically immunostained for BUdR
(reddish-brown) and p16INK4A (blue) in a, c (compare with phase-con-
trast images in b, d). Note the inverse correlation between p16 ex-
pression and BUdR incorporation, with only rare p16 non-expressing
cells found to be non-cycling. Panel b shows the results of two channel
flow cytometric analysis of a mid-lifespan culture of strain N that was
BUdR labeled for 24 h before it was trypsin suspended, fixed, perm-
eabilized, and incubated with the DNA intercalating dye propidium io-
dide to assess DNA content and fluorescent-labeled anti-BUdR
antibody to permit determination of the cycling or non-cycling charac-
ter of each cell. The non-cycling subpopulation (red) of this culture (to
the lower left of the dashed blue line) was found to be predominantly of
2n DNA content, consistent with G1 arrest, as expected for cells ar-
resting as a result of inhibition of the G1/S restriction point-specific
cyclin-dependent kinases cdk4 or cdk6.
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invasion through the basement membrane into superficial
connective tissue (Fig 6). As expected from results pub-
lished by others that the p16 locus is typically lost or si-
lenced by promoter hypermethylation in advanced, deeply
invasive SCC (reviewed by Rocco and Sidransky, 2001),
p16 protein expression proved to be lost at some point be-
tween the stages of early invasive and deeply invasive SCC
in both epidermal and oral epithelial neoplastic progression
(Fig 6).
Coordinate p16 and Lam5 expression in neoplastic pro-
gression and normal wound healing Interestingly, we
found that the same regions and many of the same cells
that expressed p16 also expressed greatly increased levels
of Lam5 (Fig 7a–c). Lam5 had been reported previously to
be associated with regions of early invasion (e.g., Pyke et al,
1995) and with the leading edge of healing epithelial
wounds (e.g., Nguyen et al, 2000a, b). We found that co-
ordinate induction of p16 and Lam5 expression occurs
in vivo in keratinocytes at the edge of skin wounds (Fig 7d–
f), and is also displayed by keratinocytes at the migrating
front of partial thickness wounds made in pieces of surgi-
cally resected human skin and subsequently maintained in
organ culture for two days (Fig 7g–i ). Lam5 and p16 also
proved to be coordinately upregulated at the edge of ex-
perimental wounds made in confluent cultures of early pas-
sage keratinocytes (Natarajan et al, 2003) (Fig 7j–l ). Taken
together, our neoplastic and wound tissue analyses and our
studies of scratch wounded, early-passage keratinocyte
cultures strongly suggest that, in vivo, a p16- and Lam5-
related KMA mechanism is triggered by an acute abnor-
mality in cell–cell or cell–substratum interaction, coupling
growth arrest with directional hypermotility. The scratch
wound result demonstrates that the KMA response is cell-
autonomous and therefore amenable to study using con-
ventional culture conditions.
Hypermotility and growth arrest induced by plating cells
on a precursor form of Lam5 These results led us to
conduct a series of experiments to determine whether KMA
can be induced synchronously in early-passage keratin-
ocyte cultures, thereby providing a useful experimental sys-
tem with which to determine the time course of activation
and the temporal and causal relationships among Lam5
expression, p16 expression, hypermotility, and growth ar-
rest. Following studies by Jones et al, described above,
which concluded that the keratinocyte wound response is
associated with a change in cell–substratum adhesion from
(a6b4 integrin: mature Lam5) to (a3b1 integrin: precursor
Lam5), we asked whether plating keratinocytes on culture
dishes coated with precursor Lam5 would induce KMA. In
our first experiments, we plated keratinocytes at a low
density onto dishes that had been precoated with medium
conditioned by the rat bladder carcinoma cell line 804G,
known to secrete Lam5 having a processed a3 chain and
unprocessed g2 chain (Baker et al, 1996; Giannelli et al,
1997) (‘‘Lam5g2pre’’). After 2 d at 371C, immunostaining
with a human Lam5-specific antibody revealed that kera-
tinocytes plated on control surfaces had formed small pads
of Lam5 and had undergone little or no net migration. In
contrast, cells plated on 804G CM-coated dishes became
hypermotile, as revealed by the tracks of Lam5 each cell left
behind. Composite low-magnification images of immuno-
stained wells were used to measure the lengths of these
tracks. As indicated in the scatterplot graph in Fig 8b, the
rate of migration stimulated over the 2 d period after plating
averaged  1500 mm per d—remarkable for these  12 mm
diameter cells.
Using purified recombinant human Lam5 (the a3-pro-
cessed, g2-precursor form: Lam5g2pre), we have confirmed
that coating dishes with 0.4 mg per mL of this protein dis-
solved in culture medium induces the same hypermotility
Figure 6
p16INK4A expression during neoplastic progression of stratified squamous epithelia toward squamous cell carcinoma (SCC) occurs at the
histopathologically classified stages of severe dysplasia to early invasion. Summarizing the principal results of Natarajan et al. (2003), the
panels show hematoxylin/eosin-stained sections (above) and p16 immunostained sections (below) of specimens of benign hyperplasia, severe
dysplasia, carcinoma in situ (non-HPV-related), and actinic keratosis overlying a deeply invasive squamous cell carcinoma. Note absence of p16
expression in benign hyperplasia, variegated pattern of p16 expression in late-stage pre-malignant lesions, and loss of p16 expression by deeply
invading, progressively growing SCC (asterisk).
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response as 804G CM. We do not have available a source
of purified recombinant Lam5 mature form to compare;
thus, we do not know whether the g2 precursor form is
essential for eliciting this response. We can conclude, how-
ever, that the a3 precursor is not essential for triggering
hypermotility. Time-lapse photography has disclosed how
quickly cells become hypermotile after plating on a recom-
binant human Lam5g2pre-coated surface. Such experi-
ments have shown that cells begin to migrate within 20 min
of attachment and spreading on a coated substratum, sug-
gesting that a change in gene expression or new protein
synthesis is not necessary to initiate hypermotility. By
measuring the distance traveled during successive 2 h
intervals of filming (i.e., 0–2, 2–4, 4–6 h, etc), the behavior
of individual cells could be determined. As shown in Fig 6c,
cells typically maintained rather constant rates of motility,
averaging about 125 mm per h during the first day after
plating.
Figure 7
Coordinate induction of p16INK4A and Laminin 5 (Lam5) expression in keratinocytes of premalignant dysplasias and in normal keratinocytes
migrating during wound healing. p16 immunostaining (b, e, h, k) and Lam5 immunostaining (c, f, i, l). Panels a–c: microinvasive region of severe
epithelial dysplasia. Panels d–e: edge of a healing skin wound (arrow indicates edge of migrating tongue of epithelium; asterisk indicates fibrin scab).
Panels g–i: wound made in an excised piece of newborn foreskin and maintained in organ culture for 2 d before immunostaining (N indicates normal,
intact epidermis; W indicates the margin of the original wound). Panels j–l: confluent culture of strain N keratinocytes scratch wounded and
maintained for 2 d before immunostaining.
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Hypermotility stimulated by precursor Lam5 is followed
by p16 expression and growth arrest We next asked
whether cells induced to become hypermotile by plating on
Lam5g2pre are growth inhibited by plating cells in control
and precoated wells and counting the cells 7 d later. As
shown in Fig 9a, cell growth was markedly inhibited on
Lam5g2pre-coated surfaces. Note that plating keratin-
ocytes on dishes coated with culture medium alone or with
fibronectin dissolved in medium resulted neither in in-
creased directional motility nor in growth inhibition. Exam-
ining the cells by immunostaining for p16 expression (Fig
9b) showed that by 1 and 4 d after plating on Lam5g2pre,
 25%–30% and  60%–70% of the cells were express-
ing p16, respectively, and by 7 d were unable to reinitiate
growth when subcultured onto a control surface (Fig 9c).
p16- and p14ARF/p53-deﬁcient keratinocytes retain the
hypermotility component but evade the growth arrest
component of the keratinocyte motility/arrest re-
sponse The immediacy of the hypermotility response, in
contrast to the slower induction of p16 and subsequent ir-
reversibility of growth arrest, indicates that p16 expression
does not induce hypermotility. Instead, some aspect of the
substratum that induces hypermotility, or the act of hyper-
motility itself, induces p16 expression and growth arrest.
This conclusion was supported by the behavior of keratin-
ocytes deficient in p16 and either p14ARF or p53. The ad-
vanced, invasive epidermal SCC-derived cell line SCC13
and normal primary keratinocytes engineered by transduct-
ion to express cdk4R24C and p53DD (N/P/C)—thereby evad-
ing p16- and p14ARF/p53- dependent arrest mechanisms,
responded to plating on Lam5g2pre with directional hyper-
motility but were not growth arrested (Fig 10). Thus, they
maintained the hypermotility component but evaded the
growth arrest component of KMA. Interestingly, one of our
TERT-immortalized lines (N/TERT-1), which had lost p16/
p14ARF expression following transduction to express TERT
as a rare heritable event associated with the emergence of
an immortalized line (Dickson et al, 2000; Fig 4a), also dis-
played a substantial resistance to Lam5g2pre-induced
Figure 8
Directional hypermotility induced in keratinocytes by plating on a culture dish pre-coated with the c2 precursor form of Laminin 5
(c2Lam5pre). Panel a shows Lam5 immunostaining of strain N keratinocyte cultures 2 d after plating at a low density in control conditions (dishes
pre-coated with fresh culture medium) or on a dish pre-treated for 30 min with medium conditioned by a confluent culture of 804G rat bladder
carcinoma cells, which secrete the1 g2 precursor form of Lam5. Note that in control conditions, cells wander little from the point at which they first
attached, as evidenced by the distribution of secreted Lam5, in contrast to the remarkable hypermotility of cells plated on a dish coated with
Lam5g2pre. Panel b shows migration distances of individual cells, determined by measuring path lengths from composite pictures assembled from
a series of adjacent microphotographic images of the immunostained culture. Panel c shows the migration distances traveled during successive 2 h
intervals by keratinocytes plated on a coverslip coated with recombinant human Lam5g2pre-dissolved in fresh culture medium and tracked by time-
lapse photography beginning at the time of plating. Note that most cells migrate at or near their maximum rate, typically 150 um per h, as soon as
they have attached to the surface.
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growth arrest (Fig 10). These results prove that neither the
expression of p16 nor its ability to cause growth arrest is
essential for the hypermotility response, and also suggest
that the p16/p14ARF arrest mechanism that is activated
asynchronously in serially passaged keratinocytes is iden-
tical to the growth arrest component of the Lam5g2pre-
induced, acute KMA response.
We are currently seeking to understand the signal path-
ways responsible for inducing the hypermotility and growth
arrest components of KMA, which at present remain a
‘‘black box’’. Our initial studies have used, as a point of
departure, observations by Decline and Rousselle (2001)
that cultured keratinocytes treated with the growth-inhibi-
tory polypeptide factor transforming growth factor beta
(TGFb) increase synthesis and secretion of the a2pre, g2pre
form of Lam5 and exhibit increased motility as assessed
using a porous filter trans-migration, Boyden chamber as-
say. We have confirmed that TGFb treatment induces a di-
rectional hypermotility response similar to that induced by
plating cells on Lam5pre (Fig 11). Lam5 track measurement
and time-lapse studies have disclosed that the hypermotility
begins about 16–24 h after exposure of cells to TGFb (data
not shown), consistent with a requirement for a change in
gene expression and new protein synthesis.
Discussion
The experiments described here have characterized the
fundamental elements of a KMA response that is activated
in keratinocytes in vivo and in culture when they encounter
certain types of abnormal substrata. In retrospect, we rec-
ognize that we first detected KMA as it is activated heter-
ogeneously in normal keratinocytes during serial culture,
where its detectable effect is to cause senescence arrest.
Keratinocyte replicative potential in culture is limited by two
independent mechanisms. One, common to all somatic cell
types, senses progressive telomere shortening and conse-
quent exposure of telomere overhang sequences by the
cells’ p53-dependent DNA damage response mechanism,
Figure 9
The hypermotility response of normal keratinocytes to Laminin 5
(Lam5)c2 precursor (Lam5c2pre) is accompanied by p16INK4A in-
duction, growth inhibition, and ultimate irreversible arrest. Panel a
shows the average population growth rate (during 7 d after plating) and
the motility response (measured 2 d after plating) of strain N keratin-
ocytes plated on fresh culture dishes or dishes pre-coated with serum-
containing medium, fibronectin, or Lam5g2pre (804G CM). Note
substantial growth inhibition and hypermotility from Lam5g2pre but
not from fibronectin. Panel b shows induction of p16INK4A protein ex-
pression, determined in individual cells by immunostaining, during the
first 4 d after plating cells on surfaces coated with 804G CM or with
purified human recombinant Lam5g2pre. Panel c shows the colony-
forming ability on fresh dishes of 1000 cells subcultured from a 7 d
control culture or from a 7 d Lam5g2pre-coated dish culture, revealing
the irreversibility of the growth arrest ensuing from long-term adhesion
to Lam5g2pre.
Figure10
p16 and p14ARF/p53 expression and function is essential for the
growth arrest component, but not the hypermotility component, of
the keratinocyte motility/arrest response to g2 precursor form of
Laminin 5 (Lam5c2pre). Growth inhibition and hypermotility responses
of keratinocyte cell lines plated on dishes pre-coated with Lam5g2pre
(804G CM). The normal primary keratinocyte line strain N at sixth
passage (  30 population doublings (PD)/mid-lifespan) showed the
normal response. Note that strain N at 13th passage (  50 PD, near-
senescence) showed little proliferation under control conditions and
significant constitutive hypermotility (as reported in Natarajan et al,
2003), which was not increased further by plating on Lam5g2pre. The
p16 expression-reduced TERT-immortalized strain line N/TERT-2G
gave results similar to that of strain N, in contrast to the p16/p14ARF/
p53-deficient lines marked by the box on the left, which exhibited a
hypermotility response to Lam5g2pre but were not substantially growth
inhibited.
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leading to expression of the cdk inhibitor p21cip1 and growth
arrest either in G1 or G2. Telomere-related senescence ar-
rest is the sole determinant of replicative lifespan/expansion
potential in culture of fibroblasts and a number of other cell
types, with p16 playing no essential role in this process
(Rheinwald et al, 2002). The other senescence mechanism,
which is p16-dependent and telomere status-independent,
is typically activated in serially cultured human keratin-
ocytes before their telomeres have shortened sufficiently to
trigger that arrest mechanism. Therefore, the p16-depend-
ent mechanism is responsible for determining the replicative
lifespan/expansion potential of keratinocytes in culture. As
summarized above and described in Dickson et al. (2000)
and Rheinwald et al (2002), serially cultured keratinocytes
exhibit an abrupt induction of p16INK4A expression and ir-
reversible growth arrest in G1 with increasing frequency at
each passage. Considering that p16 induction is triggered in
early-passage keratinocytes when plated on surfaces coat-
ed with the g2 precursor form of Lam5, keratinocytes in
serial culture may gradually lose their ability to process se-
creted Lam5 quickly enough to prevent engagement of
precursor Lam5 with their a3b1 integrin and consequently
instigate the KMA response.
The phenomenon of p16-related senescence in culture
led us to test the hypothesis that induction of p16 expres-
sion occurs in stratified squamous epithelia in vivo as a
mechanism to restrict the proliferative potential of normal
keratinocyte stem cells. Our study of hyperplastic and dys-
plastic lesions of the epidermis and oral mucosa did not
support this hypothesis but, instead, revealed that p16 ex-
pression is specifically induced in pre-malignant oral and
epidermal keratinocytes that have progressed to the stage
of incipient or initial invasion into underlying connective tis-
sue as SCC (Natarajan et al, 2003). The finding of coordi-
nate p16 and Lam5 expression at sites of severe dysplasia
and microinvasion, as well as in normal keratinocytes at the
migrating front of healing wounds, suggests a common re-
sponse by keratinocytes to these two pathologic situations.
We have conjectured (Natarajan et al, 2003) that the KMA
response evolved as part of the wound-healing process to
aid re-epithelialization but that it is also activated at a spe-
cific stage of neoplastic progression. KMA is marked (1) by
increased synthesis of Lam5 and (presumably) its deposi-
tion in an incompletely processed, g2 precursor form that
makes the cells directionally hypermotile and (2) by subse-
quent p16 expression that arrests their growth. We hypoth-
esize that sacrifice of the proliferative potential, by p16
induction, in the band of cells that are leading migration to
reepithelialize a wound may enhance the directional motility
of these cells so that they can more efficiently pull their still-
proliferative neighbors behind them to cover the wound
surface. Figure 12 illustrates our hypothetical model of how
KMA is activated during epithelial neoplastic progression.
Rare preneoplastic cells that evade the growth arrest com-
ponent of KMA, typically by ceasing to express p16, would
then be able to grow progressively as invasive SCC. Recent
studies from other laboratories have reported an increase in
p16 expression at the leading edge of healing oral mucosal
epithelial wounds (Bartkova et al, 2003) and an inverse re-
lation between p16 expression and Ki67 staining in cells at
the invading fronts of basal cell carcinoma (Svensson et al,
2003), consistent with our findings.
Identification of the cell surface and extracellular matrix
molecules that determine whether keratinocytes remain
sessile or display migratory behavior has been a subject of
active investigation for almost 20 years. Some of the earliest
work in this field recognized that some cell types increase
their motility in response to exposure to some forms of
Lam5 (Kikkawa et al, 1994) and that keratinocytes migrating
on a variety of extracellular matrix molecules secrete and
interact with endogenously produced Lam5 (Zhang and
Kramer, 1996), a conclusion that has been supported de-
finitively by recent studies (Frank and Carter, 2004). Evi-
dence to date best supports a model for keratinocyte
wound healing-related motility (Goldfinger et al, 1999; Ngu-
yen et al, 2000a, b; Decline and Rouselle, 2001) in which
keratinocytes convert from a more sessile state favored by
a6b4 integrin adhesion to mature Lam5 to a more motile
state favored by a3b1 integrin adhesion to precursor Lam5
(or, as recently suggested (Decline et al, 2003; Okamoto
Figure 11
Transforming growth factor beta (TGFb) induces directional hyper-
motility in keratinocytes plated on control surfaces. Strain N
keratinocytes were plated on fresh culture dishes in medium
containing 1 ng per mLTGFb1. Two days later, cultures were immuno-
stained for Laminin 5 (Lam5) to reveal migration tracks (panel a), which
were measured and compared (panel b) with those induced in the same
experiment by plating cells in medium without TGFb but on surfaces
pre-coated with human recombinant Lam5  2pre.
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et al, 2003), syndecan-1 adhesion to Lam5). Further pro-
teolytic cleavage of the g2 chain at a specific site indicated
by the small black arrow in Fig 3 has been found in some
cancer cell lines in culture, as a result of MMP-2 and/or
MT1-MMP action, thereby releasing soluble fragments of
g2-containing epidermal growth factor (EGF)-like repeats
that have been reported to stimulate motility measured by
the transwell migration assay (Giannelli et al, 1997; Ko-
shikawa et al, 2000; Gilles et al, 2001; Schenk et al, 2003). It
is important to note that, since we do not currently have a
source of purified recombinant mature Lam5 (i.e., with both
the a3 and g2 chains processed), we do not know whether
an abnormally high concentration of Lam5 in any form might
be able to trigger the KMA response.
Frank and Carter (2004) have termed the type of direc-
tional hypermotility that we have found exhibited by newly
senescent cells (Natarajan et al, 2003) and by early-passage
cells plated on Lam5g2pre surfaces (results presented here)
as ‘‘persistent, processive’’ motility. Either term is suitably
descriptive and serves to distinguish this type of cell move-
ment from that of ‘‘sessile’’ cells in culture, which time-lapse
photography reveals are actually very active and motile, but
move within a confined area by frequently changing direc-
tion or by rotating. Studies using Lam5 immunostaining or
colloidal gold displacement to detect migration, such as
used by Zhang and Kramer (1996); Nguyen et al (2000a, b);
Decline and Rousselle (2001); Li et al, (2001, 2004); Henry
et al (2003); Frank and Carter (2004), and Natarajan et al,
(2003), have the potential, depending upon the method
used for quantitation, of distinguishing directional migration
from non-persistent, non-directional motility. The method
we used, Lam5 immunostaining to reveal 2 d track lengths
of individual cells, can detect and quantitate the specific
type of motility characteristic of the KMA response. This
method, therefore, has an advantage over Boyden chamber
transwell migration assays, colloidal gold area clearance
measurements, or visual scoring for a scattered appearance
of colonies for accurately assessing effects of experimental
agents or altered gene expression on wound- and invasion-
related directional hypermotility.
In a small survey of soluble factors that might be ex-
pected to influence keratinocyte migration, we found that
high concentrations of EGF and hepatocyte growth factor
did not induce hypermotility (data not shown), but that
TGFb, a potent keratinocyte growth inhibitor (for example,
see Shipley et al, 1986; Rollins et al, 1989) induced a di-
rectional hypermotility in keratinocytes plated on control
surfaces that was similar to that displayed by cells plated on
Lam5g2pre. Decline et al. (2003) had reported that TGFb-
treated keratinocytes reduce their display of a6b4 integrin,
predominantly begin depositing completely unprocessed
Lam5 (i.e., the a3pre, g2pre form) on their substratum, and
become more motile.
Our cell culture model experiments, summarized here
and described more completely elsewhere (Natarajan et al,
submitted), have elucidated the temporal and causal rela-
tionships among Lam5g2pre exposure, directional hyper-
motility, p16 expression, and growth arrest. Of central
importance is that KMA is a sequential, two-step process:
hypermotility occurs quickly, followed later by p16 expres-
sion and a growth inhibition that ultimately becomes
irreversible. Neither p16 expression nor growth arrest is es-
sential to the hypermotility response. SCC cells, normal
keratinocytes engineered to resist the inhibitory effects of
p16 and p14ARF, and some TERT-immortalized keratinocyte
lines that acquired loss of p16 and p14ARF expression still
become hypermotile in response to Lam5pre-induced KMA
but are not growth inhibited. Thus, neither receptor tyrosine
kinase-initiated mitogen signaling pathways nor expression
of essential cell cycling proteins such as cyclin D1, c-myc,
etc., are shut down, blocked, or impaired in hypermotile
cells. Our results are consistent with the invasive behavior of
p16-deficient SCC cells in vivo.
The working model shown in Fig 13 summarizes our own
findings to date about the KMA response in the context
of discoveries by others about the mechanisms of
Lam5g2pre:integrin engagement and TGFb-instigated
growth arrest. The box outlined by a dashed line indicates
the (many) signaling molecules and pathways that remain to
be characterized. These include the events downstream of
integrin engagement by Lam5g2pre that lead to immediate
hypermotility, the events that induce expression of p16 and
p14ARF to cause growth arrest, and the events downstream
of TGFb receptor activation that result in hypermotility and
growth arrest. We are currently investigating the possibility
of cross-talk and shared signal pathway events between
Lam5g2pre-induced and TGFb-induced KMA. We have be-
gun studies using signal pathway kinase-specific inhibitory
drugs, seeking to identify signaling steps that are either
unique to hypermotility or else can be modulated by
concentrations of drugs that impair motility without caus-
ing an acute, p16-unrelated growth inhibition. We are aug-
Figure 12
A model for the p16/laminin 5 (Lam5)-related keratinocyte motility/
arrest response in epithelial neoplastic progression. The diagram
shows normal engagement of the basal layer of stratified squamous
epithelia with mature, processed Lam5 via a6b4 integrin, in contrast to
dysplastic cells that have progressed to a stage at which they are
breaking down and beginning to penetrate the basement membrane.
We hypothesize that this stimulates increased expression of Lam5,
some of which remains in its precursor form and engages the motility-
related integrins a3b1, and possibly also a2b1 (see Goldfinger et al,
1999; Nguyen et al, 2000b; Decline and Rousselle, 2001). The increas-
ingly darker shades of brown color indicate induction of p16 protein
expression in these cells, which results in cell cycle arrest and acts as a
tumor suppressor to prevent progressive growth. If a rare p16-deficient
variant arises within the lesion, it can continue dividing while invading
as a squamous cell carcinoma.
LAMININ 5 AND p16INK4A IN KERATINOCYTE MOTILITY 8110 : 2 NOVEMBER 2005
menting this approach with the design and expression of
specific RNAi vectors to knock down expression of candi-
date signal pathway proteins and assess the consequence
to the hypermotility and growth arrest components of the
keratinocyte motility/arrest response.
Materials and Methods
Cell lines and cell culture The derivation and properties of the
cell lines used in these experiments (see Table I) have been de-
scribed (Rheinwald and Beckett, 1981; Dickson et al, 2000;
Rheinwald et al, 2002). Keratinocytes were cultured in the ‘‘kera-
tinocyte serum-free medium (K-sfm)’’ formulation (Pirisi et al, 1987)
supplied by GIBCO/Invitrogen, (Carlsbad, California) supplement-
ed as described previously (Rheinwald et al, 2002) with 25 mg per
mL bovine pituitary extract (BPE), 0.2 ng per mL EGF, and 0.4 mM
CaCl2. To generate near-confluent or confluent cultures, cells were
grown to about 40% confluence in K-sfm, then refed with a me-
dium consisting of a 1:1 (vol:vol) mixture of calcium-free DMEM
medium (GIBCO/Invitrogen), and 0.4 mM CaCl2-supplemented
complete K-sfm, which permits formation of healthy, confluent,
modestly stratified cultures. For some experiments, keratinocytes
were cultured using the fibroblast feeder layer system (Rheinwald
and Green, 1975; Allen-Hoffmann and Rheinwald, 1984), in which
keratinocytes are co-cultured with mitomycin-treated 3T3J2 cells
in FAD medium, consisting of DMEM/F12 (1:1 vol/vol) medium
(GIBCO, Invitrogen)þ 5% calf serum (CS) (Hyclone, Logan, Utah),
10 ng per mL EGF, 0.4 mg per mL hydrocortisone (HC), 5 mg per mL
insulin, 10  1010 M cholera toxin (CT), 2  1011 M triiodothyro-
nine, and 1.8  104 M adenine. 804G cells (Izumi et al, 1981) were
cultured in DMEM supplemented with 10% newborn calf serum
(Hyclone).
Antibodies and immunostaining The human p16INK4A-specific
mouse monoclonal antibody G175-405 (Pharmingen, San Jose,
California) was used at 2 mg per mL and the Lam5 g2 chain-specific
mouse monoclonal antibody D4B5 (Mizushima et al, 1998) (Chem-
icon, Temecula, California) was used at 10 mg per mL. The Lam5 g2
chain-specific rabbit polyclonal antibody J20 (Goldfinger et al,
1998) was used at 1:40 dilution. Details of the methods for
immunostaining tissue sections and cultured cells are described in
Natarajan et al. (2003). Images were captured on a NIKON E600
Microscope (Nikon, Melville, New York) with a SPOT2 digital cam-
era using SPOTcam v.3.5.5 software (Diagnostic Instruments,
Sterling Heights, Michigan).
Puriﬁcation of recombinant human Lam5, c2 precursor
form The 293 cells were sequentially transfected with pcDNA3.1
plasmids expressing the complete coding sequences of each of
the three chains of human Lam5. The b3 subunit sequence con-
tained a C-terminal 6-His tag. Transfected 293 cells were grown to
confluence and then switched to serum-free medium for two days,
conditioned medium was then harvested and laminin-5 purified
over a His-Bind column (Novagen, San Diego, California). The
eluted Lam5 consisted of a3 chain in its cleaved, mature form but
the g2 chain in its precursor, uncleaved 155 kDa form, as deter-
mined by western blotting with the D4B5 antibody (data not
shown).
Assay for acute KMA induction and modulation by extracel-
lular matrix proteins and polypeptide factors A six-well tissue
culture plates ( 9 cm2 area per well per 1.5 mL medium volume)
(Costar Corning, New York) were pretreated by incubation with
conditioned medium (CM) from confluent cultures of 804G cells or
with solutions of purified extracellular matrix proteins dissolved in
10% calf serum-supplemented DMEMaF12 medium for 30 min at
room temperature, and then were rinsed and used to plate cells in
K-sfm medium. To measure directional hypermotility, wells plated
with 500 cells were fixed in 4% paraformaldehyde 40 h later and
immunostained with a Lam5g2-specific monoclonal antibody using
the ABC peroxidase method (Natarajan et al, 2003). Six to twelve
adjoining fields were photographed using a 2  objective and the
path lengths of at least 30 cells were measured. To assess growth
inhibition, wells plated with 2,000 cells were permitted to grow for
7 d, with refeeding on days 3 and 5. Cells were trypsinized and
counted, and the average growth rate was calculated as log2 [#
cells counted/#cells plated]/7 days¼population doublings (PD)/
day. The average (mean) migration path length and degree of
growth inhibition (as measured by PD/day growth rate) were com-
pared between control and experimental conditions.
Time-lapse photography Keratinocytes were inoculated into a
temperature-controlled heated chamber (Mike’s Machine Compa-
ny, Boston, Massachusetts) assembled with a 25 mm diameter
Nalge/Nunc Thermonox (Rochester, New York) plastic coverslip,
which was pre-coated with control medium or with medium con-
Figure 13
A working model of c2 precursor form of Laminin 5 (Lam5c2pre)-
induced and transforming growth factor beta-induced hypermo-
tility and growth arrest in keratinocytes.
Table I. Human keratinocyte cell lines
Cell type of origin Cell line name Donor age, sex Known p16, p14ARF, and p53 genetic abnormalities Replicative lifespan
Epidermal keratinocyte Strain N Newborn, M None  60 PD
Epidermal keratinocyte N/p53DD/cdk4R Newborn, M Functionally p53- and p16-deficient  95 PD
Epidermal keratinocyte N/TERT-1 Newborn, M None (but expresses no p16 or p14ARF) Immortal
Epidermal keratinocyte N/TERT-2G Newborn, M None (but reduced p16 expression) Immortal
Epidermal SCC SCC-13 56, F p16(/), p53(/) Immortal
PD, population doublings; SCC, squamous cell carcinoma.
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taining Lam5g2pre. A Zeiss (Zeiss, Go¨ttingen, Germany) IM35
inverted microscope (Diagnostic Instruments) equipped with a
Uniblitz Model VMM-D1 Shutter Driver (Vincent Associates,
Rochester, New York), and a Spot Insight QE camera was used
to capture images through a  10 phase objective and  10
eyepiece (total magnification  100). Images collected at 5 min
intervals using Spot version 4.0.4. software were converted into
movies, which were examined to trace and measure the path
lengths of cells.
Culture wound models Scratch wound assay: Linear ‘‘wounds’’
 2 mm wide were made in 1d post-confluent keratinocyte cul-
tures (prepared as described above) by scraping the point of a
sterile Eppendorf pipette tip across the cells, after which the cul-
tures were returned to the incubator for 40 h until fixation and
immunocytochemical analysis.
Organ cultured human skin wound assay: 1 cm2 pieces of
recently resected human newborn foreskin were rinsed in medium
to remove residual blood components and  2 mm diameter
wounds were made through the epidermis and partially into the
dermis with the aid of a fine forceps and curved iris scissors. The
wounded pieces were submerged in medium and placed in the
incubator for 2 d, after which they were fixed, sectioned, immuno-
stained, and analyzed.
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